InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Smith Cynthia, Director. Insider active across 2 companies, notably Akebia Therapeutics, Inc.. Aggregated, 7 filings have been logged. The latest transaction was disclosed on 8 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
013,700 shares0
Common Stock
SEC:0001562180-22-004977:0·
€112,5223,333 shares@ €33.7598100.0% of flow
Common Stock
SEC:0001399529-21-000204·
€112,5223,333 shares@ €33.759850.0% of flow
Common Stock
SEC:0001399529-21-000204:0·
3,333 shares
Common Stock
SEC:0001399529-21-000110·
3,333 shares
Common Stock
SEC:0001399529-21-000110:0·
013,700 shares0
Common Stock
SEC:0001562180-21-004030·
013,700 shares0
Common Stock
SEC:0001562180-21-004030:0·
7 of 7 declarations
About Smith Cynthia
Cynthia Smith is a Board Member at Akebia Therapeutics, Inc. and Dicerna Pharmaceuticals Inc. She brings her expertise in corporate governance and strategy, contributing to the direction and decision-making within these organizations. Her role involves overseeing operations and ensuring compliance with regulatory standards while supporting the mission of the companies in the biopharmaceutical sector.
